论文部分内容阅读
中药材市场的情况是如此之糟。那么中成药的情况又如何呢?据了解,我国是世界上最大的中成药生产国,目前有中成药生产企业1000余家,还有大约2000家西药厂也生产中成药,2001年总产值大约52亿美元。但在所有中成药生产企业中,通过国家GMP标准的不足10％,绝大多数中药企业规模都很小,所生产的药品外观粗糙、剂型落后,缺乏研究开发能力,生产工艺和设备落后,很难有国际竞争力。
The situation of the Chinese herbal medicine market is so bad. Then, what about the situation of proprietary Chinese medicines? It is understood that China is the world’s largest producer of Chinese patent medicines. There are currently more than 1,000 Chinese patent medicine manufacturing companies, and approximately 2,000 western medicine companies also produce proprietary Chinese medicines. The total production value in 2001 was about 52 billion U.S. dollars. However, in all Chinese patent medicine manufacturing enterprises, less than 10% of the national GMP standards have passed, and the vast majority of Chinese medicine companies have small scales. The medicines produced have a rough appearance and are backward in formulation, lack of research and development capabilities, and have poor production technology and equipment. Difficult to have international competitiveness.